In advance of the American Board of Surgery's Flexible Endoscopy Curriculum rollout, surgical residents and their program directors need to prepare for the mandate, General Surgery News reports.
GI & Endoscopy
A study in the International Journal of Cancer suggests that regular use of glucosamine and chondroitin sulfate lower the risk of developing colon cancer by 23 percent, the Wall Street Journal reports.
The prevalence of inflammatory bowel disease among adults in the United States may look different than previous estimates, according to research presented in the CDC's Morbidity and Mortality Weekly Report series.
Exact Sciences' Cologuard has been awarded the Galien Foundation's 2016 Prix Galien USA Award for "best medical technology product."
Karel Rybnicek, MD, is a gastroenterologist at Cleveland Gastroenterology Associates.
Advertisement
After experiencing steady growth in adaptation since 2001, the $178.8 million global endoscopy market is predicted to grow at a CAGR of 14.8 percent through 2020, according to a report by Wise Guy Reports.
Here are the five most popular Becker's ASC Review gastroenterology and endoscopy stories for the week of Oct. 24 to Oct. 28.
Glen Daves, MD, is a gastroenterologist with South Carolina-based Gastroenterology Associates.
Here are three gastroenterologists in the news this past week.
Allergan is in the midst of acquiring Motus Therapeutics, a subsidiary of Rhythm Holding Company, after its relamorelin prescription achieved top line results in a phase 2b clinical trial.